| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/02/2000 | US6057128 MU-1, member of the cytokine receptor family |
| 05/02/2000 | US6057126 Polynucleotide sequence coding human binding polypeptide associated with signal transduction; for treatment and prevention of cancer, inflammation, psoriasis and arthritis; wound healing agents; antiproliferative agents |
| 05/02/2000 | US6057124 Nucleic acids encoding ligands for HEK4 receptors |
| 05/02/2000 | US6057112 Ubiquitin conjugation proteins |
| 05/02/2000 | US6057108 Human ARF-related proteins |
| 05/02/2000 | US6057104 Disruption of the mammalian Rad51 protein and disruption of proteins that associate with mammalian Rad51 for hindering cell proliferation |
| 05/02/2000 | US6057103 Detecting proteins coded in genomic nucleotide sequences; obtaining single stranded nucleotide sequences, incubating with probe, isolating bound nucleotide sequences, transforming cells, recovering desired proteins |
| 05/02/2000 | US6056959 CD40 antigen antibody complex |
| 05/02/2000 | US6056952 Selective elimination of T cells that recognize specific preselected targets |
| 05/02/2000 | US6056951 Method of reducing the chance of attack of cells in a body by the cellular immune system |
| 05/02/2000 | US6055936 Sea cucumber carotenoid lipid fractions and process |
| 05/02/2000 | CA2023968C Living tissue equivalents |
| 05/02/2000 | CA1340982C Protamine-reactive igm antibodies |
| 04/27/2000 | WO2000023806A1 Detection and quantification of vancomycin in biological fluids |
| 04/27/2000 | WO2000023621A2 Visualization of rna in living cells |
| 04/27/2000 | WO2000023615A2 Method for extracting quantitative information relating to an influence on a cellular response |
| 04/27/2000 | WO2000023605A1 cDNA SEQUENCE TRANSCRIBING A mRNA CODING FOR THE TERMINAL OXYDASE ASSOCIATED WITH CAROTENOID BIOSYNTHESIS AND USES |
| 04/27/2000 | WO2000023602A2 Regulated expression using conditional er retention domains |
| 04/27/2000 | WO2000023601A1 Delivery system for porcine somatotropin |
| 04/27/2000 | WO2000023600A1 Materials and methods involving conditional aggregation domains |
| 04/27/2000 | WO2000023594A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 04/27/2000 | WO2000023593A2 Molecular pathogenicide mediated plant disease resistance |
| 04/27/2000 | WO2000023588A2 G-protein coupled receptors |
| 04/27/2000 | WO2000023587A2 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
| 04/27/2000 | WO2000023582A1 Gene transfer cell sheet and process for preparing the same |
| 04/27/2000 | WO2000023580A1 A method of affinity separation and ligands for use therein |
| 04/27/2000 | WO2000023575A1 Ups (ugc) |
| 04/27/2000 | WO2000023573A2 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023571A2 A method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells |
| 04/27/2000 | WO2000023570A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | WO2000023567A2 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023473A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | WO2000023472A2 Interferon-beta fusion proteins and uses |
| 04/27/2000 | WO2000023466A2 Human rna binding proteins |
| 04/27/2000 | WO2000023465A2 Methods and reagents for isolating biologically active peptides |
| 04/27/2000 | WO2000023459A1 Inhibitors of platelet activation and recruitment |
| 04/27/2000 | WO2000023116A1 Adeno-associated vectors for expression of factor viii by target cells |
| 04/27/2000 | WO2000023112A1 Modulation of gene expression by combination therapy |
| 04/27/2000 | WO2000023100A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | WO2000023094A2 Methods of inhibiting platelet activation and recruitment |
| 04/27/2000 | WO2000023084A1 Methods for stimulating the regeneration of inner ear cells |
| 04/27/2000 | WO2000023082A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 04/27/2000 | WO2000023053A2 Artificial antigen-specific cells and related methods |
| 04/27/2000 | WO2000023008A2 Cardiovascular components for transplantation and methods of making thereof |
| 04/27/2000 | WO2000022932A1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 04/27/2000 | WO2000012559B1 Monoclonal antibodies against s100 |
| 04/27/2000 | WO2000008149A3 Human neuronal acid-sensitive cationic channels, its cloning and applications |
| 04/27/2000 | WO2000006742A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/27/2000 | WO2000005386A3 Chorismate biosynthesis enzymes |
| 04/27/2000 | WO2000005265A3 Anti-crr2 antibodies and methods of use therefor |
| 04/27/2000 | WO2000004152A3 Androgen receptor coactivators |
| 04/27/2000 | WO2000004141A3 Use of nucleic acid molecules as antiviral agents |
| 04/27/2000 | WO2000003008A3 Recombinant haploid or diploid yarrowia lipolytica cells for the functional heterologous expression of cytochrome p450 systems |
| 04/27/2000 | WO2000000618A3 Polyketides and their synthesis |
| 04/27/2000 | WO1999064586A3 Phagocytic assay method |
| 04/27/2000 | WO1999061586A9 Promotion of cell differentiation by initially passaged cells |
| 04/27/2000 | WO1999057271A9 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 04/27/2000 | WO1999055844A3 Methods for modulating differentiation |
| 04/27/2000 | WO1999050406A9 Growth differentiation factor-9 regulatory sequences and uses therefor |
| 04/27/2000 | WO1998056811A8 Plant grab proteins |
| 04/27/2000 | DE19849073A1 Transgene encoding amyloid precursor protein or its fragment, used to produce transgenic nematodes used, e.g. to screen for agents for treating Alzheimer's disease |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | DE19848517A1 Controlling phytopathogenic fungi, useful particularly against Botrytis cinerea resistant to known fungicides, by treatment with peptide from Streptomyces tendae |
| 04/27/2000 | DE19842863A1 Regulatorisches Protein aus humanen Keratinozyten Regulatory protein from human keratinocytes |
| 04/27/2000 | CA2633345A1 A method of affinity separation and ligands for use therein |
| 04/27/2000 | CA2354862A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 04/27/2000 | CA2348153A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | CA2348068A1 Adeno-associated vectors for expression of factor viii by target cells |
| 04/27/2000 | CA2347706A1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 04/27/2000 | CA2347654A1 Human rna binding proteins |
| 04/27/2000 | CA2347625A1 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2347062A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | CA2347003A1 Modulation of gene expression by combination therapy |
| 04/27/2000 | CA2346841A1 Cardiovascular components for transplantation and methods of making thereof |
| 04/27/2000 | CA2346799A1 Delivery system for porcine somatotropin |
| 04/27/2000 | CA2346798A1 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | CA2346717A1 Detection and quantification of vancomycin in biological fluids |
| 04/27/2000 | CA2346500A1 Methods and reagents for isolating biologically active peptides |
| 04/27/2000 | CA2346152A1 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 04/27/2000 | CA2345382A1 Inhibitors of platelet activation and recruitment |
| 04/27/2000 | CA2344605A1 G-protein coupled receptors |
| 04/27/2000 | CA2343974A1 Materials and methods involving conditional aggregation domains |
| 04/27/2000 | CA2343917A1 Materials and methods involving conditional retention domains |
| 04/27/2000 | CA2343094A1 Interferon-beta fusion proteins and uses |
| 04/26/2000 | EP0995802A2 Method for the delivery of nucleic acids to cells in vitro or ex vivo |
| 04/26/2000 | EP0995795A2 Human recombinant cell for bone or cartilage cell binding |
| 04/26/2000 | EP0995445A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 04/26/2000 | EP0995238A1 A method of reducing signal coupling in a connector, a connector and a cable including such a connector |
| 04/26/2000 | EP0995121A1 C-peptide specific assay procedure |
| 04/26/2000 | EP0994966A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 04/26/2000 | EP0994962A1 An indexed library of cells containing genomic modifications and methods of making and utilizing the same |
| 04/26/2000 | EP0994958A2 Selective regulation of adenovirus production |
| 04/26/2000 | EP0994957A1 Transgenic plants using the tdc gene for crop improvement |
| 04/26/2000 | EP0994956A1 Male tissue-preferred regulatory region and method of using same |
| 04/26/2000 | EP0994954A1 T7 promoter-based expression system |
| 04/26/2000 | EP0994953A1 Expression system for production of therapeutic proteins |
| 04/26/2000 | EP0994951A1 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |